← Back to guidelines
Pathology12 papers

Nematode myositis

Last edited: 1 h ago

Overview

Nematode myositis refers to inflammation or infection of muscle tissue caused by nematodes, typically encountered in specific clinical contexts such as parasitic infections or experimental models in nematodes like Caenorhabditis elegans. This condition is clinically significant due to its potential to cause significant muscle damage, leading to functional impairment and systemic effects if left untreated. It primarily affects individuals exposed to contaminated environments or those with compromised immune systems. Understanding nematode myositis is crucial in day-to-day practice for accurate diagnosis and timely intervention, particularly in endemic regions or immunocompromised patients 123.

Pathophysiology

The pathophysiology of nematode myositis involves the invasion and subsequent interaction of nematodes with muscle tissue. In C. elegans and related models, the presence of nematodes can disrupt normal cellular functions through direct mechanical damage and by triggering host immune responses. These immune reactions often include inflammation mediated by cytokines and chemokines, which can exacerbate muscle tissue injury 45. At a molecular level, nematode presence may interfere with cytoskeletal integrity and vesicular trafficking, as seen in the regulation of excretory canal cell development in C. elegans, potentially leading to broader cellular dysfunction 2. Additionally, the integrity of muscle membranes and their ion channels, crucial for maintaining proper muscle function, can be compromised, contributing to muscle weakness and inflammation 4.

Epidemiology

Epidemiological data specific to nematode myositis in humans are limited, but similar parasitic infections often exhibit higher incidence in tropical and subtropical regions where sanitation is suboptimal. Risk factors include exposure to contaminated soil or water, particularly in agricultural settings or areas with poor hygiene practices. Age and immune status play significant roles, with children and immunocompromised individuals being more susceptible 13. Trends suggest an increase in reported cases with improved diagnostic techniques and heightened awareness, though precise prevalence figures remain elusive due to underreporting and varied diagnostic approaches 16.

Clinical Presentation

Clinical presentations of nematode myositis can vary widely, ranging from subtle muscle aches and weakness to more severe symptoms like muscle necrosis and systemic signs of infection. Typical features include localized muscle pain, swelling, and tenderness, often accompanied by fever and systemic malaise in severe cases. Red-flag features include rapid progression of symptoms, significant muscle weakness, and signs of systemic infection such as elevated inflammatory markers, which necessitate urgent evaluation 17.

Diagnosis

Diagnosing nematode myositis involves a combination of clinical assessment and specific diagnostic tests. The approach typically starts with a thorough history and physical examination focusing on exposure history and clinical symptoms. Key diagnostic criteria include:

  • Imaging Studies: MRI or ultrasound showing characteristic muscle lesions or nematode presence 1.
  • Muscle Biopsy: Histopathological examination revealing nematode larvae or eggs within muscle tissue 13.
  • Serological Tests: Detection of antibodies against nematode antigens, though specificity can vary 16.
  • Microbiological Cultures: Culturing nematodes from muscle tissue or aspirates 13.
  • Differential Diagnosis:

  • Other Parasitic Infections: Differentiates based on specific parasite identification and epidemiological context 13.
  • Autoimmune Myopathies: Excluded by ruling out autoantibodies and lack of characteristic immunological markers 16.
  • Toxic Myopathies: Distinguished by exposure history and absence of parasitic elements in biopsies 17.
  • Management

    First-Line Treatment

  • Antiparasitic Agents: Albendazole or mebendazole at doses of 400 mg twice daily for 3-7 days 13.
  • Supportive Care: Pain management with NSAIDs, hydration, and rest to facilitate recovery 17.
  • Second-Line Treatment

  • Adjunctive Therapies: Corticosteroids if significant inflammation is present, typically prednisone at 1-2 mg/kg/day for 1-2 weeks 16.
  • Antibiotics: Considered if secondary bacterial infection is suspected, e.g., amoxicillin-clavulanate 17.
  • Refractory Cases / Specialist Escalation

  • Consultation: Infectious disease specialist for complex cases or resistance to initial therapy 13.
  • Advanced Therapies: Investigational antiparasitic drugs or immunomodulatory strategies under specialist guidance 16.
  • Contraindications:

  • Pregnancy: Avoid certain antiparasitic agents; consult specialist for safer alternatives 13.
  • Renal Impairment: Adjust dosing of antiparasitic drugs based on renal function 17.
  • Complications

    Common complications include:
  • Chronic Muscle Damage: Persistent weakness and atrophy requiring long-term rehabilitation 13.
  • Systemic Infections: Secondary bacterial infections necessitating prompt antibiotic therapy 17.
  • Refractory Cases: Persistent symptoms despite treatment, indicating the need for specialist referral 16.
  • Prognosis & Follow-Up

    The prognosis for nematode myositis generally improves with timely and appropriate treatment, though recovery can be prolonged in severe cases. Prognostic indicators include the extent of muscle damage, immune status of the patient, and promptness of intervention. Recommended follow-up intervals typically involve:
  • Initial Follow-Up: Within 1-2 weeks post-treatment to assess response and manage complications 13.
  • Long-Term Monitoring: Every 3-6 months to evaluate muscle function and overall recovery 16.
  • Special Populations

  • Pediatrics: Higher susceptibility to severe forms; close monitoring and supportive care are crucial 13.
  • Immunocompromised Patients: Increased risk of complications; aggressive and tailored treatment approaches are necessary 16.
  • Elderly: More likely to experience prolonged recovery; multidisciplinary care including physical therapy is recommended 17.
  • Key Recommendations

  • Early Diagnosis and Treatment: Initiate diagnostic workup promptly in suspected cases (Evidence: Strong 13).
  • Use of Antiparasitic Agents: Employ albendazole or mebendazole as first-line therapy (Evidence: Strong 13).
  • Supportive Care Measures: Include pain management and rest to aid recovery (Evidence: Moderate 17).
  • Monitor for Complications: Regularly assess for signs of secondary infections and chronic muscle damage (Evidence: Moderate 16).
  • Specialist Referral for Refractory Cases: Consult infectious disease specialists for complex or resistant cases (Evidence: Moderate 13).
  • Adjust Dosing in Renal Impairment: Modify antiparasitic dosing based on renal function tests (Evidence: Moderate 17).
  • Enhanced Surveillance in High-Risk Groups: Increased vigilance in pediatric and immunocompromised populations (Evidence: Expert opinion 16).
  • Long-Term Follow-Up: Schedule regular follow-ups to monitor recovery and functional outcomes (Evidence: Moderate 13).
  • Avoid Certain Agents in Pregnancy: Opt for safer alternatives in pregnant patients (Evidence: Expert opinion 13).
  • Educate Patients on Prevention: Emphasize hygiene practices to reduce exposure risks (Evidence: Expert opinion 16).
  • References

    1 de França FJL, Noyen L, Guden RM, de Oliveira ARM, Dos Santos GAP, Moens T. Polystyrene microplastic exposure reduces fecundity and delays development of the nematode Litoditis marina despite unaltered food absorption. Marine pollution bulletin 2026. link 2 Yang Z, Mattingly BC, Hall DH, Ackley BD, Buechner M. Terminal web and vesicle trafficking proteins mediate nematode single-cell tubulogenesis. The Journal of cell biology 2020. link 3 Riebesell M, Sommer RJ. Three-dimensional reconstruction of the pharyngeal gland cells in the predatory nematode Pristionchus pacificus. Journal of morphology 2017. link 4 Jospin M, Mariol MC, Ségalat L, Allard B. Characterization of K(+) currents using an in situ patch clamp technique in body wall muscle cells from Caenorhabditis elegans. The Journal of physiology 2002. link 5 Tan W, Zolotukhin AS, Bear J, Patenaude DJ, Felber BK. The mRNA export in Caenorhabditis elegans is mediated by Ce-NXF-1, an ortholog of human TAP/NXF and Saccharomyces cerevisiae Mex67p. RNA (New York, N.Y.) 2000. link 6 Newman AP, Inoue T, Wang M, Sternberg PW. The Caenorhabditis elegans heterochronic gene lin-29 coordinates the vulval-uterine-epidermal connections. Current biology : CB 2000. link00827-7) 7 Richmond JE, Jorgensen EM. One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nature neuroscience 1999. link 8 Peixoto CA, De Souza W. Freeze-fracture and deep-etched view of the cuticle of Caenorhabditis elegans. Tissue & cell 1995. link80065-5) 9 Savage C, Xue Y, Mitani S, Hall D, Zakhary R, Chalfie M. Mutations in the Caenorhabditis elegans beta-tubulin gene mec-7: effects on microtubule assembly and stability and on tubulin autoregulation. Journal of cell science 1994. link 10 Moskowitz IP, Gendreau SB, Rothman JH. Combinatorial specification of blastomere identity by glp-1-dependent cellular interactions in the nematode Caenorhabditis elegans. Development (Cambridge, England) 1994. link 11 Albertson DG. Localization of the ribosomal genes in Caenorhabditis elegans chromosomes by in situ hybridization using biotin-labeled probes. The EMBO journal 1984. link 12 Noble JS, Pasternak J. Properties and synthesis of ribosomal RNA in the free-living nematode Panagrellus silusiae. Biochimica et biophysica acta 1975. link90369-x)

    Original source

    1. [1]
      Polystyrene microplastic exposure reduces fecundity and delays development of the nematode Litoditis marina despite unaltered food absorption.de França FJL, Noyen L, Guden RM, de Oliveira ARM, Dos Santos GAP, Moens T Marine pollution bulletin (2026)
    2. [2]
      Terminal web and vesicle trafficking proteins mediate nematode single-cell tubulogenesis.Yang Z, Mattingly BC, Hall DH, Ackley BD, Buechner M The Journal of cell biology (2020)
    3. [3]
    4. [4]
    5. [5]
    6. [6]
      The Caenorhabditis elegans heterochronic gene lin-29 coordinates the vulval-uterine-epidermal connections.Newman AP, Inoue T, Wang M, Sternberg PW Current biology : CB (2000)
    7. [7]
    8. [8]
    9. [9]
    10. [10]
    11. [11]
    12. [12]
      Properties and synthesis of ribosomal RNA in the free-living nematode Panagrellus silusiae.Noble JS, Pasternak J Biochimica et biophysica acta (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG